ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

January 16, 2009

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

ACS Medals Of Honor To Bonadonna, Hsu, Louis Sullivan

December 13, 1991

In Brief: Bristol Dedicates New Research center; MSK Presents Awards to Sen. Moyniham, 10 Others

July 11, 1986

UT System Chancellor to Travel to MD Anderson After Faculty Senate Survey Finds Plunging Morale

September 6, 2013

History: Breast Cancer Screening A 30-Year War Against “Confusion”

November 20, 2009